Towards reforming the taxonomy of human disease: The Precisesads cross sectional study
L Laigle
(1)
,
Lorenzo Beretta
(2)
,
J Wojick
(3)
,
J Mavorac
(4)
,
Jacques-Olivier Pers
(5)
,
Bernard R Lauwerys
(6)
,
J Frostegard
(7)
,
F Mac Donald
(8)
,
M Juarez
(4)
,
Benschop R
(9)
,
E Dow
(10)
,
S Rao
(11)
,
C Chamberlain
(4)
,
J Martin
(12)
,
Marta E. Alarcon-Riquelme
(13)
1
Immuno-inflammatory Disease, IRIS -
Center for Therapeutic Innovation , Suresnes
2 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
3 Quartzbio, Geneva
4 UCB BioPharma
5 LBAI - Lymphocytes B, Autoimmunité et Immunothérapies
6 UCL - Université Catholique de Louvain = Catholic University of Louvain
7 Karolinska Institutet [Stockholm]
8 Bayer Pharma AG [Berlin]
9 Eli Lilly & Company
10 Eli Lilly & Company
11 Sanofi-Aventis Research
12 Instituto de Parasitología y Biomedicina
13 Centre for Genomics and Oncological Reearch (GENYO)
2 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
3 Quartzbio, Geneva
4 UCB BioPharma
5 LBAI - Lymphocytes B, Autoimmunité et Immunothérapies
6 UCL - Université Catholique de Louvain = Catholic University of Louvain
7 Karolinska Institutet [Stockholm]
8 Bayer Pharma AG [Berlin]
9 Eli Lilly & Company
10 Eli Lilly & Company
11 Sanofi-Aventis Research
12 Instituto de Parasitología y Biomedicina
13 Centre for Genomics and Oncological Reearch (GENYO)
L Laigle
- Fonction : Auteur
- PersonId : 1256664
- IdHAL : lydie-laigle
- ORCID : 0009-0001-4851-7995
Jacques-Olivier Pers
- Fonction : Auteur
- PersonId : 753610
- IdHAL : jacques-olivier-pers
- ORCID : 0000-0001-7287-5541
- IdRef : 068262159